Literature DB >> 11586468

Cytokine receptors and signaling in hepatic stellate cells.

M Pinzani1, F Marra.   

Abstract

Following acute or chronic liver tissue damage, hepatic stellate cells (HSCs) undergo a process of activation toward a phenotype characterized by increased proliferation, motility, contractility, and synthesis of extracellular matrix components. Activation of HSCs is regulated by several soluble factors, including growth factors, cytokines, chemokines, and products of oxidative stress, as well as by extensive changes in the composition and organization of the ECM. Different groups of soluble factors may be classified according to their prevalent biological effect: (a) factors promoting HSC proliferation and/or migration (i.e., platelet-derived growth factor, basic fibroblast growth factor, insulin-like growth factor-1); (b) factors promoting fibrillar ECM accumulation, particularly transforming growth factor-beta1; (c) factors with a prevalent contractile effect on HSCs, such as endothelin-1, thrombin, angiotensin-II and vasopressin, although all these agents also may promote HSC proliferation; (d) proinflammatory cytokines and chemokines; and (e) cytokines with a prominent antiinflammatory/antifibrogenic activity, such as interleukin-10 and interferon-gamma. Additional important issues are represented by the relationship between cytokine and integrin signaling, and by the effects of oxidative stress-related molecules on cytokine signaling. In the past decade the major intracellular signaling pathways elicited by these factors in HSCs have been greatly elucidated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11586468     DOI: 10.1055/s-2001-17554

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  116 in total

1.  Stellate cells in the digestive tract.

Authors:  Hendrik Reynaert; Filip Sermon; Daniel Urbain; Albert Geerts
Journal:  Curr Gastroenterol Rep       Date:  2003-06

2.  Expression of basic fibroblast growth factor in rat liver fibrosis and hepatic stellate cells.

Authors:  Xiaodong Peng; Bo Wang; Tancai Wang; Qiu Zhao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

3.  All-trans retinoic acid diminishes collagen production in a hepatic stellate cell line via suppression of active protein-1 and c-Jun N-terminal kinase signal.

Authors:  Yuan Ye; Zili Dan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-12-22

4.  Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C.

Authors:  M Diago; G Castellano; J García-Samaniego; C Pérez; I Fernández; M Romero; O L Iacono; C García-Monzón
Journal:  Gut       Date:  2005-09-08       Impact factor: 23.059

5.  Effects of adrenomedullin gene overexpression on biological behavior of hepatic stellate cells.

Authors:  Yi Wang; Jin-Sheng Zhang; Guang-Cun Huang; Qi Cheng; Zhong-Hua Zhao
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

Review 6.  Interleukin-10 and chronic liver disease.

Authors:  Li-Juan Zhang; Xiao-Zhong Wang
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

7.  Kangxian ruangan keli inhibits hepatic stellate cell proliferation mediated by PDGF.

Authors:  Ling Yang; Chi-Zhi Zhang; Qing-Jing Zhu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

Review 8.  Treatment of hepatic fibrosis: almost there.

Authors:  Efsevia Albanis; Rifaat Safadi; Scott L Friedman
Journal:  Curr Gastroenterol Rep       Date:  2003-02

9.  Effects of the tyrosine protein kinase inhibitor genistein on the proliferation, activation of cultured rat hepatic stellate cells.

Authors:  Xiao-Jing Liu; Li Yang; Yong-Qiu Mao; Qiong Wang; Ming-Hui Huang; Yi-Ping Wang; Hong-Bin Wu
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

10.  CCR1 and CCR5 promote hepatic fibrosis in mice.

Authors:  Ekihiro Seki; Samuele De Minicis; Geum-Youn Gwak; Johannes Kluwe; Sayaka Inokuchi; Christina A Bursill; Josep M Llovet; David A Brenner; Robert F Schwabe
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.